Two prostate cancer mutations reveal opposite responses to ferroptosis therapy

A caller survey by researchers astatine The University of Texas MD Anderson Cancer Center has identified familial factors that find whether prostate cancers are susceptible to a benignant of compartment decease known arsenic ferroptosis. These findings, published successful Nature Communications, could assistance usher attraction strategies for patients whose tumors bash not respond to existent attraction options.